Continuation of beta-blockers during prolonged dobutamine infusion in heart transplant–prioritised patients: A competing-risk analysis
Joao Manoel Rossi Neto, Victor Bemfica de Mello Mattos, Airton Salviano Sousa Junior, Marco Aurelio Finger, Raphael Machado Rossi, Plinio Jose Whitaker Wolf, Carlo Bonasso Filho, Flavia Potsch Camara Mattos Girard · 2026
Read Continuation of beta-blockers during prolonged dobutamine infusion in heart transplant–prioritised patients: A competing-risk analysis by Joao Manoel Rossi Neto, Victor Bemfica de Mello Mattos, Airton Salviano Sousa Junior, Marco Aurelio Finger, Raphael Machado Rossi, Plinio Jose Whitaker Wolf, Carlo Bonasso Filho, Flavia Potsch Camara Mattos Girard (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0354128.txt.
Description
Joao Manoel Rossi Neto and colleagues studied a tense drug question. It faces people waiting for a heart transplant. Their analysis appeared in PLOS ONE in 2026. Many such patients survive on a drip of dobutamine. That drug helps the heart pump. Clinicians disagree about also giving beta-blocker pills. The two drugs pull in opposite directions.
The team looked back at fifty-three patients. All had tolerated both drugs for at least a month. Those who stayed on beta-blockers reached transplant far more often. They also died before surgery far less. The sample is small, and the authors urge caution. Still, the results argue for prospective trials.
Catalog record
| CREATOR | Joao Manoel Rossi Neto, Victor Bemfica de Mello Mattos, Airton Salviano Sousa Junior, Marco Aurelio Finger, Raphael Machado Rossi, Plinio Jose Whitaker Wolf, Carlo Bonasso Filho, Flavia Potsch Camara Mattos Girard |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 33048 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |